SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?


To: celeryroot.com who wrote (3274)8/21/1998 11:49:00 AM
From: Jeffrey S. Mitchell  Respond to of 4028
 
Ahhh... another Pluvia vs. Westergaard connection. For those that don't remember, Westergaard is paid to promote stocks (sound familiar), and launched a crusade to rid the internet of Pluvia by unmasking him. To that end he offered a $5000 bounty to anyone who could do so. You see, Pluvia had been telling people that PLSIA, under contract from Westergaard, was cooking their books. A year later, sure enough, the SEC proved Pluvia correct. Now it appears we've got an analyst in hot water for stock manipulation. Other times its the promoters. Moral: if you focus just on the company, let alone just the present and future aspects of a company, you miss the big picture. With penny stocks, if you ignore the big picture 9 times out of 10 you'll be toast, IMO.

- Jeff



To: celeryroot.com who wrote (3274)8/21/1998 11:57:00 AM
From: Graham Marshman  Respond to of 4028
 
Thanks,
Incidentally, I just did a quick check on some recent FDA
timelines. The FDA, as you probably know, issues a statement of total
time (in days) of both the testing and approval phases on approved
items in order to allow patent extensions. I took all the ones
reported since 8/9, eliminated one device, one food additive and one
animal product, leaving only drugs. For those five, I tabulated
total time in test phase and total time from IND to approval.
See below:

Drug Test period(days) Total period(days)
Mirapex 2024 2576
Etopophos 1029 1719
Posicon 1326 1793
Dostinex 1825 2188
Benefix 583 749

These were approved in 96/97 so still not very current, but
interesting. Average total period to approval was 4.9 years with a
max time of 7 years.

Let me just state here that this is statistically insignificant, but I
was just taking a quick sample. Looks encouraging that the FDA may be
somewhat better than the 12 year peg.
Graham



To: celeryroot.com who wrote (3274)8/22/1998 6:40:00 PM
From: Mr. Forthright  Respond to of 4028
 
If Jay is Graham's biotech "analyst/promoter" hero, I know what to think of Graham.